Company intelligence / Profile preview

Eyenuk

Woodland Hills / Los Angeles, California, United States

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Eyenuk's flagship product, the EyeArt AI system, has received FDA clearance as the first autonomous AI technology to detect both more-than-mild and vision-threatening diabetic retinopathy. It also holds CE marking under EU MDR regulations for detecting diabetic retinopathy, AMD, and glaucomatous optic nerve damage. The system delivers results in less than a minute at point-of-care settings and has been validated by major health authorities including the UK NHS and Health Canada. Clinical studies have demonstrated high sensitivity/specificity in real-world settings.

Therapeutic areas: OphthalmologyCardiovascularNeurology
Modalities: Device (AI-enabled diagnostic system)Software (AI/ML algorithms for image analysis)Non-pharmacological therapy (diagnostic platform)
Industry: Medical Imaging

Drug pipeline

1 asset

EyeArt

Commercial

Indications: Diabetic Retinopathy

Partnerships

Collaborations with Doheny Eye Institute; University of California Berkeley Optometry; Cedars Sinai Los Angeles; LA County Department of Health Services; Washington University School of Medicine St. Louis MO; The University of Manchester UK

Beyond the preview

Go deeper on Eyenuk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eyenuk.

Explore the full profile